Ambica Agarbathies Aroma & Industries Limited
Ambica Agarbathies Aroma & Industries Limited (AMBICAAGAR.NS) Stock Competitors & Peer Comparison
See (AMBICAAGAR.NS) competitors and their performances in Stock Market.
Peer Comparison Table: Household & Personal Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AMBICAAGAR.NS | ₹23.94 | +1.27% | 417.2M | 32.82 | ₹0.74 | N/A |
| HINDUNILVR.BO | ₹2,209.55 | +0.55% | 5.2T | 47.78 | ₹46.24 | +1.95% |
| HINDUNILVR.NS | ₹2,209.40 | +0.59% | 5.2T | 48.91 | ₹45.17 | +1.95% |
| MARICO.NS | ₹830.00 | +0.81% | 1.1T | 61.03 | ₹13.60 | +0.84% |
| MARICO.BO | ₹829.95 | +0.67% | 1.1T | 62.88 | ₹13.20 | +0.84% |
| GODREJCP.BO | ₹1,032.20 | +0.96% | 1.1T | 57.96 | ₹17.81 | +1.94% |
| GODREJCP.NS | ₹1,031.80 | +1.12% | 1.1T | 56.72 | ₹18.19 | +1.94% |
| DABUR.BO | ₹447.85 | +0.16% | 794.3B | 43.19 | ₹10.37 | +1.79% |
| DABUR.NS | ₹447.60 | +0.09% | 793.9B | 42.07 | ₹10.64 | +1.79% |
| COLPAL.BO | ₹2,077.45 | -0.88% | 565B | 42.50 | ₹48.88 | +2.46% |
Stock Comparison
AMBICAAGAR.NS vs HINDUNILVR.BO Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, HINDUNILVR.BO has a market cap of 5.2T. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while HINDUNILVR.BO trades at ₹2,209.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas HINDUNILVR.BO's P/E ratio is 47.78. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to HINDUNILVR.BO's ROE of +0.31%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to HINDUNILVR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check HINDUNILVR.BO's competition here
AMBICAAGAR.NS vs HINDUNILVR.NS Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, HINDUNILVR.NS has a market cap of 5.2T. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while HINDUNILVR.NS trades at ₹2,209.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas HINDUNILVR.NS's P/E ratio is 48.91. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to HINDUNILVR.NS's ROE of +0.31%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to HINDUNILVR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check HINDUNILVR.NS's competition here
AMBICAAGAR.NS vs MARICO.NS Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, MARICO.NS has a market cap of 1.1T. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while MARICO.NS trades at ₹830.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas MARICO.NS's P/E ratio is 61.03. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to MARICO.NS's ROE of +0.43%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to MARICO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check MARICO.NS's competition here
AMBICAAGAR.NS vs MARICO.BO Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, MARICO.BO has a market cap of 1.1T. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while MARICO.BO trades at ₹829.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas MARICO.BO's P/E ratio is 62.88. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to MARICO.BO's ROE of +0.43%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to MARICO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check MARICO.BO's competition here
AMBICAAGAR.NS vs GODREJCP.BO Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, GODREJCP.BO has a market cap of 1.1T. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while GODREJCP.BO trades at ₹1,032.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas GODREJCP.BO's P/E ratio is 57.96. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to GODREJCP.BO's ROE of +0.15%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to GODREJCP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check GODREJCP.BO's competition here
AMBICAAGAR.NS vs GODREJCP.NS Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, GODREJCP.NS has a market cap of 1.1T. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while GODREJCP.NS trades at ₹1,031.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas GODREJCP.NS's P/E ratio is 56.72. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to GODREJCP.NS's ROE of +0.15%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to GODREJCP.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check GODREJCP.NS's competition here
AMBICAAGAR.NS vs DABUR.BO Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, DABUR.BO has a market cap of 794.3B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while DABUR.BO trades at ₹447.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas DABUR.BO's P/E ratio is 43.19. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to DABUR.BO's ROE of +0.17%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to DABUR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check DABUR.BO's competition here
AMBICAAGAR.NS vs DABUR.NS Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, DABUR.NS has a market cap of 793.9B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while DABUR.NS trades at ₹447.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas DABUR.NS's P/E ratio is 42.07. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to DABUR.NS's ROE of +0.17%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to DABUR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check DABUR.NS's competition here
AMBICAAGAR.NS vs COLPAL.BO Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, COLPAL.BO has a market cap of 565B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while COLPAL.BO trades at ₹2,077.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas COLPAL.BO's P/E ratio is 42.50. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to COLPAL.BO's ROE of +0.82%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to COLPAL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check COLPAL.BO's competition here
AMBICAAGAR.NS vs COLPAL.NS Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, COLPAL.NS has a market cap of 564.9B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while COLPAL.NS trades at ₹2,077.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas COLPAL.NS's P/E ratio is 42.61. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to COLPAL.NS's ROE of +0.82%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to COLPAL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check COLPAL.NS's competition here
AMBICAAGAR.NS vs PGHH.BO Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, PGHH.BO has a market cap of 320.7B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while PGHH.BO trades at ₹9,880.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas PGHH.BO's P/E ratio is 44.64. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to PGHH.BO's ROE of +1.03%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to PGHH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check PGHH.BO's competition here
AMBICAAGAR.NS vs PGHH.NS Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, PGHH.NS has a market cap of 320.5B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while PGHH.NS trades at ₹9,873.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas PGHH.NS's P/E ratio is 44.83. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to PGHH.NS's ROE of +1.03%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to PGHH.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check PGHH.NS's competition here
AMBICAAGAR.NS vs GILLETTE.BO Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, GILLETTE.BO has a market cap of 257.3B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while GILLETTE.BO trades at ₹7,897.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas GILLETTE.BO's P/E ratio is 48.22. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to GILLETTE.BO's ROE of +0.58%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to GILLETTE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check GILLETTE.BO's competition here
AMBICAAGAR.NS vs GILLETTE.NS Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, GILLETTE.NS has a market cap of 257.1B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while GILLETTE.NS trades at ₹7,891.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas GILLETTE.NS's P/E ratio is 48.28. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to GILLETTE.NS's ROE of +0.58%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to GILLETTE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check GILLETTE.NS's competition here
AMBICAAGAR.NS vs EMAMILTD.NS Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, EMAMILTD.NS has a market cap of 176.3B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while EMAMILTD.NS trades at ₹403.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas EMAMILTD.NS's P/E ratio is 22.73. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to EMAMILTD.NS's ROE of +0.28%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to EMAMILTD.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check EMAMILTD.NS's competition here
AMBICAAGAR.NS vs EMAMILTD.BO Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, EMAMILTD.BO has a market cap of 176.3B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while EMAMILTD.BO trades at ₹403.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas EMAMILTD.BO's P/E ratio is 22.75. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to EMAMILTD.BO's ROE of +0.28%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to EMAMILTD.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check EMAMILTD.BO's competition here
AMBICAAGAR.NS vs CUPID.BO Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, CUPID.BO has a market cap of 172B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while CUPID.BO trades at ₹127.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas CUPID.BO's P/E ratio is 161.96. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to CUPID.BO's ROE of +0.29%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to CUPID.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check CUPID.BO's competition here
AMBICAAGAR.NS vs CUPID.NS Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, CUPID.NS has a market cap of 171.9B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while CUPID.NS trades at ₹127.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas CUPID.NS's P/E ratio is 161.82. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to CUPID.NS's ROE of +0.29%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to CUPID.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check CUPID.NS's competition here
AMBICAAGAR.NS vs HONASA.NS Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, HONASA.NS has a market cap of 128.8B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while HONASA.NS trades at ₹396.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas HONASA.NS's P/E ratio is 64.92. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to HONASA.NS's ROE of +0.16%. Regarding short-term risk, AMBICAAGAR.NS is less volatile compared to HONASA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check HONASA.NS's competition here
AMBICAAGAR.NS vs HONASA.BO Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, HONASA.BO has a market cap of 128.7B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while HONASA.BO trades at ₹395.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas HONASA.BO's P/E ratio is 64.82. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to HONASA.BO's ROE of +0.16%. Regarding short-term risk, AMBICAAGAR.NS is less volatile compared to HONASA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check HONASA.BO's competition here
AMBICAAGAR.NS vs JYOTHYLAB.NS Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, JYOTHYLAB.NS has a market cap of 75.3B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while JYOTHYLAB.NS trades at ₹204.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas JYOTHYLAB.NS's P/E ratio is 22.01. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to JYOTHYLAB.NS's ROE of +0.19%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to JYOTHYLAB.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check JYOTHYLAB.NS's competition here
AMBICAAGAR.NS vs JYOTHYLAB.BO Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, JYOTHYLAB.BO has a market cap of 75.3B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while JYOTHYLAB.BO trades at ₹204.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas JYOTHYLAB.BO's P/E ratio is 21.99. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to JYOTHYLAB.BO's ROE of +0.19%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to JYOTHYLAB.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check JYOTHYLAB.BO's competition here
AMBICAAGAR.NS vs BAJAJCON.NS Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, BAJAJCON.NS has a market cap of 72.8B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while BAJAJCON.NS trades at ₹554.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas BAJAJCON.NS's P/E ratio is 38.96. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to BAJAJCON.NS's ROE of +0.26%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to BAJAJCON.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check BAJAJCON.NS's competition here
AMBICAAGAR.NS vs BAJAJCON.BO Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, BAJAJCON.BO has a market cap of 72.4B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while BAJAJCON.BO trades at ₹554.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas BAJAJCON.BO's P/E ratio is 39.06. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to BAJAJCON.BO's ROE of +0.26%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to BAJAJCON.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check BAJAJCON.BO's competition here
AMBICAAGAR.NS vs ALLTIME.NS Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, ALLTIME.NS has a market cap of 15.5B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while ALLTIME.NS trades at ₹236.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas ALLTIME.NS's P/E ratio is 43.25. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to ALLTIME.NS's ROE of +0.07%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to ALLTIME.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check ALLTIME.NS's competition here
AMBICAAGAR.NS vs BCLIND.NS Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, BCLIND.NS has a market cap of 9.7B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while BCLIND.NS trades at ₹32.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas BCLIND.NS's P/E ratio is 8.27. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to BCLIND.NS's ROE of +0.14%. Regarding short-term risk, AMBICAAGAR.NS is less volatile compared to BCLIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check BCLIND.NS's competition here
AMBICAAGAR.NS vs KAYA.BO Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, KAYA.BO has a market cap of 3.7B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while KAYA.BO trades at ₹246.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas KAYA.BO's P/E ratio is -4.34. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to KAYA.BO's ROE of +0.73%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to KAYA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check KAYA.BO's competition here
AMBICAAGAR.NS vs KAYA.NS Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, KAYA.NS has a market cap of 3.7B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while KAYA.NS trades at ₹245.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas KAYA.NS's P/E ratio is -4.33. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to KAYA.NS's ROE of +0.73%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to KAYA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check KAYA.NS's competition here
AMBICAAGAR.NS vs ADORMUL.BO Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, ADORMUL.BO has a market cap of 1.3B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while ADORMUL.BO trades at ₹135.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas ADORMUL.BO's P/E ratio is -29.80. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to ADORMUL.BO's ROE of -0.32%. Regarding short-term risk, AMBICAAGAR.NS is less volatile compared to ADORMUL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check ADORMUL.BO's competition here
AMBICAAGAR.NS vs PCCOSMA.BO Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, PCCOSMA.BO has a market cap of 864M. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while PCCOSMA.BO trades at ₹326.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas PCCOSMA.BO's P/E ratio is 10.78. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to PCCOSMA.BO's ROE of +0.16%. Regarding short-term risk, AMBICAAGAR.NS is less volatile compared to PCCOSMA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check PCCOSMA.BO's competition here
AMBICAAGAR.NS vs JHS.NS Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, JHS.NS has a market cap of 793.6M. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while JHS.NS trades at ₹9.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas JHS.NS's P/E ratio is -14.41. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to JHS.NS's ROE of -0.03%. Regarding short-term risk, AMBICAAGAR.NS is less volatile compared to JHS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check JHS.NS's competition here
AMBICAAGAR.NS vs JHS.BO Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, JHS.BO has a market cap of 789.3M. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while JHS.BO trades at ₹9.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas JHS.BO's P/E ratio is -9.92. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to JHS.BO's ROE of -0.03%. Regarding short-term risk, AMBICAAGAR.NS is less volatile compared to JHS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check JHS.BO's competition here
AMBICAAGAR.NS vs STDSFAC.BO Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, STDSFAC.BO has a market cap of 421.3M. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while STDSFAC.BO trades at ₹50.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas STDSFAC.BO's P/E ratio is N/A. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to STDSFAC.BO's ROE of N/A. Regarding short-term risk, AMBICAAGAR.NS is less volatile compared to STDSFAC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check STDSFAC.BO's competition here
AMBICAAGAR.NS vs AMBICAAGAR.BO Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, AMBICAAGAR.BO has a market cap of 410.5M. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while AMBICAAGAR.BO trades at ₹23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas AMBICAAGAR.BO's P/E ratio is 82.41. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to AMBICAAGAR.BO's ROE of +0.01%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to AMBICAAGAR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check AMBICAAGAR.BO's competition here
AMBICAAGAR.NS vs NKIND.NS Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, NKIND.NS has a market cap of 381.6M. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while NKIND.NS trades at ₹63.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas NKIND.NS's P/E ratio is -6.17. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to NKIND.NS's ROE of +0.02%. Regarding short-term risk, AMBICAAGAR.NS is less volatile compared to NKIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check NKIND.NS's competition here
AMBICAAGAR.NS vs NUWAY.BO Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, NUWAY.BO has a market cap of 354.6M. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while NUWAY.BO trades at ₹37.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas NUWAY.BO's P/E ratio is 14.40. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to NUWAY.BO's ROE of N/A. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to NUWAY.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check NUWAY.BO's competition here
AMBICAAGAR.NS vs NKIND.BO Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, NKIND.BO has a market cap of 350.7M. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while NKIND.BO trades at ₹58.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas NKIND.BO's P/E ratio is -5.67. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to NKIND.BO's ROE of +0.02%. Regarding short-term risk, AMBICAAGAR.NS is less volatile compared to NKIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check NKIND.BO's competition here
AMBICAAGAR.NS vs PAOS.BO Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, PAOS.BO has a market cap of 308.8M. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while PAOS.BO trades at ₹50.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas PAOS.BO's P/E ratio is -9.57. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to PAOS.BO's ROE of +0.22%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to PAOS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check PAOS.BO's competition here
AMBICAAGAR.NS vs SATTVASUKU.BO Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, SATTVASUKU.BO has a market cap of 287.7M. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while SATTVASUKU.BO trades at ₹0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas SATTVASUKU.BO's P/E ratio is -75.00. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to SATTVASUKU.BO's ROE of +0.09%. Regarding short-term risk, AMBICAAGAR.NS is less volatile compared to SATTVASUKU.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check SATTVASUKU.BO's competition here
AMBICAAGAR.NS vs HIPOLIN.BO Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, HIPOLIN.BO has a market cap of 284.8M. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while HIPOLIN.BO trades at ₹90.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas HIPOLIN.BO's P/E ratio is -9.09. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to HIPOLIN.BO's ROE of -0.35%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to HIPOLIN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check HIPOLIN.BO's competition here
AMBICAAGAR.NS vs PARMCOS-B.BO Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, PARMCOS-B.BO has a market cap of 174.8M. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while PARMCOS-B.BO trades at ₹36.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas PARMCOS-B.BO's P/E ratio is 327.27. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to PARMCOS-B.BO's ROE of +0.00%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to PARMCOS-B.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check PARMCOS-B.BO's competition here
AMBICAAGAR.NS vs CORNE.BO Comparison May 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 417.2M. In comparison, CORNE.BO has a market cap of 48.5M. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹23.94, while CORNE.BO trades at ₹9.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 32.82, whereas CORNE.BO's P/E ratio is -5.71. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to CORNE.BO's ROE of +0.09%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to CORNE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check CORNE.BO's competition here